Totect Side Effects
Generic Name: dexrazoxane,dexrazoxane hydrochloride
Please note - some side effects for Totect may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Totect Side Effects - for the Professional
Totect
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, the adverse reaction rates observed cannot be directly compared to rates in other trials and may not reflect the rates observed in clinical practice.
In the clinical studies, Totect® was administered to patients also receiving chemotherapeutic agents for cancer, and the adverse reaction profile reflects the combination of Totect®, underlying disease, and already administered chemotherapy. The adverse reaction data reflect exposure to Totect® in 80 patients who received the first dose, 72 patients who received two doses, and 69 patients who received all three doses. Table 1 summarizes adverse reactions occurring with ≥ 5% frequency.
| MedDRA System Organ Class (SOC) and Preferred term | Study 1 and 2 Combined (All causalities) N=80 (%) |
|---|---|
| Total number of patients with at least one event | 68 (85) |
| General disorders and administration site conditions | 46 (58) |
| Pyrexia | 17 (21) |
| Injection site pain/injection site discomfort | 13 (16) |
| Fatigue | 10 (13) |
| Edema peripheral | 8 (10) |
| Injection site phlebitis | 5 (6) |
| Gastrointestinal disorders | 44 (55) |
| Nausea | 34 (43) |
| Vomiting | 15 (19) |
| Diarrhea | 9 (11) |
| Abdominal pain | 5 (6) |
| Constipation | 5 (6) |
| Infections and infestations | 24 (30) |
| Postoperative infection | 13 (16) |
| Nervous system disorders | 19 (24) |
| Dizziness | 9 (11) |
| Headache | 5 (6) |
| Skin and subcutaneous disorders | 14 (18) |
| Alopecia | 11 (14) |
| Respiratory, thoracic and mediastinal disorders | 13 (16) |
| Dyspnea | 6 (8) |
| Pneumonia Cough |
5 (6) 4 (5) |
| Vascular disorders | 12 (15) |
| Blood and lymphatic system disorders | 11 (14) |
| Anemia | 5 (6) |
| Psychiatric disorders | 11 (14) |
| Depression Insomnia |
6 (8) 4 (5) |
| Musculoskeletal and connective tissue disorders | 10 (13) |
| Metabolism and nutrition disorders Anorexia |
8 (10) 4 (5) |
| Cardiac disorders | 4 (5) |
Neutropenia and febrile neutropenia each occurred in 2.5% of patients.
Table 2 summarizes laboratory adverse events from studies 1 and 2.
| CTCAE version 3 Term |
CTC grade 3 | CTC grade 4 | CTC grade 2 to 4 |
| N (%) | N (%) | N (%) | |
| Hematologic: | |||
| Decreased hemoglobin | 2 (3) | 0 | 34 (43) |
| Decreased WBC | 20 (25) | 16 (20) | 58 (73) |
| Decreased neutrophils | 17 (22) | 19 (24) | 48 (61) |
| Decreased platelets | 17 (21) | 0 | 21 (26) |
| Hepatic: | |||
| Increased bilirubin | 1 (2) | 0 | 6 (11) |
| Increased AST | 1 (1) | 1 (1) | 21 (28) |
| Increased ALT | 1 (1) | 4 (5) | 17 (22) |
| Increased alkaline phosphatase | 0 | 0 | 3 (4) |
| Increased LDH | 0 | 0 | 1 (5) |
| Metabolic: | |||
| Increased creatinine | 1 (2) | 1 (2) | 8 (14) |
| Decreased sodium | 4 (5) | 1 (1) | 5 (6) |
| Increased calcium total | 1 (2) | 1 (2) | 4 (7) |
Side Effects by Body System - for Healthcare Professionals
Gastrointestinal
Gastrointestinal side effects including nausea (43%), vomiting (19%), diarrhea (11%), abdominal pain (6%), and constipation (6%) have been reported.
General
General side effects including pyrexia (21%), postoperative infection (16%), fatigue (13%), peripheral edema (10%), chest pain, chest discomfort, decreased drug effect, hyperpyrexia, and decreased therapeutic response have been reported.
Local
Local side effects including injection site pain (16%) and injection site phlebitis (6%) have been reported.
Cardiovascular
Cardiovascular side effects including vascular disorders (15%) and cardiac disorders (5%) have been reported.
Dermatologic
Dermatologic side effects including alopecia (14%) have been reported.
Musculoskeletal
Musculoskeletal side effects including "musculoskeletal and connective tissue disorders" (13%) have been reported.
Nervous system
Nervous system side effects including dizziness (11%) and headache (6%) have been reported.
Respiratory
Respiratory side effects including dyspnea (8%), pneumonia (6%), and cough (5%) have been reported.
Psychiatric
Psychiatric side effects including depression (8%), anorexia (5%), and insomnia (5%) have been reported.
Hematologic
Hematologic side effects including anemia (6%), decreased WBC, decreased neutrophils, and decreased platelets have been reported.
Hepatic
Hepatic side effects including increased bilirubin, increased AST, increased ALT, increased alkaline phosphatase, and increased LDH have been reported
Metabolic
Metabolic side effects including increased creatinine, decreased sodium, and increased total calcium have been reported.
TopMore Totect resources
- Totect Consumer Overview
- Totect Prescribing Information (FDA)
- Totect Advanced Consumer (Micromedex) - Includes Dosage Information
- Dexrazoxane Prescribing Information (FDA)
- Dexrazoxane Professional Patient Advice (Wolters Kluwer)
- Dexrazoxane MedFacts Consumer Leaflet (Wolters Kluwer)
- Dexrazoxane Hydrochloride Monograph (AHFS DI)
- Zinecard Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
